Who We Are
At Tenomix, our mission is to develop novel technologies that target inefficiencies in the pathology workflow, optimize cancer care, and reduce healthcare costs. We have a dedicated team of engineers, medical doctors, and clinical scientists currently working on a novel solution called The Lymphonator.
26,900 Canadians were diagnosed with colorectal cancer in 2020, which translated to 74 Canadians being diagnosed every day. Globally, almost 2 million people were diagnosed with colorectal cancer.
Pathology staff perform the search for lymph nodes by hand, which makes the process labour, time, and resource intensive. Crucially, given the limitations of human touch, smaller lymph nodes may be missed.
The Lymphonator, a bench-top robotic scanning device that guides the hospital's pathology team in efficient and reliable lymph node identification in surgically removed colorectal cancer tissues.
At Tenomix, our vision is to be at the forefront of pathology innovation,
ensuring pathology staff are equipped with the right tools that help provide the best patient care.